Pharmacovigilance Programme of India

Pharmacovigilance Programme of India
Organisation overview
Formed2010 (2010)
TypeRegulatory body
Parent departmentIndian Pharmacopoeia Commission
Websitecdsco.gov.in/opencms/opencms/en/PvPI/

The Pharmacovigilance Programme of India (PvPI) is an Indian government organization which identifies and responds to drug safety problems.[1] Its activities include receiving reports of adverse drug events and taking necessary action to remedy problems.[1] The Central Drugs Standard Control Organisation established the program in July 2010 [1][2] with All India Institute of Medical Sciences, New Delhi as the National Coordination Centre, which later shifted to Indian Pharmacopoeia Commission in Ghaziabad on 15 April 2011.[1][2]

  1. ^ a b c d Indian Pharmacopoeia Commission (2014). "Guidance Document for Spontaneous Adverse Drug Reaction Reporting" (PDF). p. 2.
  2. ^ a b Cite error: The named reference Thatte 2018 was invoked but never defined (see the help page).
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.